GlassScriptPhysician profile
Amanda D Wilcox
NPI 1669763868
$10,346.94
in general payments reported to CMS, 2019-2025
53 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,932 · 2020: $2,118 · 2021: $2,320 · 2022: $1,922 · 2023: $1,421 · 2024: $635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,056.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,223.81 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,141.83 | 2019-2024 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $1,125.59 | 2019-2024 | Vraylar, Qulipta, Ubrelvy |
| Lilly USA, LLC | $913.19 | 2019-2024 | Jardiance, Mounjaro |
| Pfizer INC. | $509.54 | 2019-2024 | |
| Glaxosmithkline, LLC. | $453.97 | 2019-2024 | Shingrix, Trelegy Ellipta |
| Allergan, INC. | $431.57 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $404.37 | 2019-2023 | Xifaxan, Trulance |
| Janssen Pharmaceuticals, INC | $398.48 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $354.05 | 2019-2024 | Jardiance, Synjardy, Trijardy Xr |
| Amgen INC. | $332.50 | 2019-2024 | Otezla, Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $259.83 | 2019-2024 | Trintellix |
| Eisai INC. | $167.23 | 2020-2021 | |
| Imperative Care, INC | $150.29 | 2023 | Zoom 88-T Large Distal Platform, Zoom Rdl Radial Access System, 103cm |
| Merck Sharp & Dohme LLC | $146.22 | 2019-2021 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Wilcox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.